Patrick Lin, Chief Officer of Processa Pharmaceuticals PCSA, has filed 9 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $24.4K. The latest trade was on 06/15.

PL

PL

Patrick Lin

Chief Business - Strategy Off

Company

Processa Pharmaceuticals PCSA

First filing

23/01/04

Trades

35 trades

Buys / sales

9 / 0

12-month net buying

$24.4K

Last trade

06/15

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Processa PharmaceuticalsPCSA	Open-market buy	06/15	06/16	1,831 sh	$2.22	$4,064.82	+20.0%
Processa PharmaceuticalsPCSA	Open-market buy	05/29	06/01	1,582 sh	$2.57	$4,065.74	+20.8%
Processa PharmaceuticalsPCSA	Open-market buy	05/15	05/19	1,369 sh	$2.97	$4,065.93	+22.0%
Processa PharmaceuticalsPCSA	Open-market buy	04/30	05/01	1,511 sh	$2.69	$4,064.59	+32.0%
Processa PharmaceuticalsPCSA	Open-market buy	04/15	04/17	1,369 sh	$2.97	$4,065.93	+40.8%
Processa PharmaceuticalsPCSA	Open-market buy	03/31	04/01	1,603 sh	$2.54	$4,071.62	+91.4%
Processa PharmaceuticalsPCSA	Open-market buy	25/01/27	25/01/29	43,500 sh	$0.80	$34,800	No record
Processa PharmaceuticalsPCSA	Open-market buy	24/01/31–24/02/01	24/02/01	4,000 sh2 trades	$2.38avg.	$9,525	+17.0%